The epidemiology of anemia in pediatric inflammatory bowel disease: Prevalence and associated factors at diagnosis and follow-up and the impact of exclusive enteral nutrition

Inflammatory Bowel Diseases

Volumn 19, Issue 11, 2013, Pages 2411-2422

  Gerasimidis, Konstantinos ^a   Barclay, Andrew ^b   Papangelou, Alexandros ^a   Missiou, Despoina ^a   Buchanan, Elaine ^b   Tracey, Cardigan ^b   Tayler, Rachel ^b   Russell, Richard K ^b   Edwards, Christine A ^a   McGrogan, Paraic ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Anemia; Exclusive enteral nutrition; Inflammatory bowel disease; Pediatrics

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; HEMOGLOBIN;

ADOLESCENT; ANEMIA; ARTICLE; BODY MASS; CHILD; CROHN DISEASE; DIAGNOSIS; ENTERIC FEEDING; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; ULCERATIVE COLITIS; WEIGHT GAIN;

ADOLESCENT; ANEMIA; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; ENTERAL NUTRITION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; PREVALENCE; PROGNOSIS;

EID: 84888220537     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e31829ed855     Document Type: Article

References (35)

1. Sawczenko A, Sandhu BK. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child. 2003;88:995-1000.
2. Hyams JS, Mandel F, Ferry GD, et al. Relationship of common laboratory parameters to the activity of Crohns disease in children. J Pediatr Gastroenterol Nutr. 1992;14:216-222.
3. Gerasimidis K, McGrogan P, Edwards CA. The aetiology and impact of malnutrition in paediatric inflammatory bowel disease. J Hum Nutr Diet. 2011;24:313-326.
4. Wells CW, Lewis S, Barton JR, et al. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis. 2006;12:123-130.
5. Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohns disease. Aliment Pharmacol Ther. 2006;24:1507-1523.
6. Goodhand JR, Kamperidis N, Rao A, et al. Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:513-519.
7. Wiskin AE, Fleming BJ, Wootton SA, et al. Anaemia and iron deficiency in children with inflammatory bowel disease. J Crohns Colitis. 2012;6:687-691.
8. Howarth LJ, Wiskin AE, Griffiths DM, et al. Outcome of childhood ulcerative colitis at 2 years. Acta Paediatr. 2007;96:1790-1793.
9. Khan K, Schwarzenberg SJ, Sharp H, et al. Role of serology and routine laboratory tests in childhood inflammatory bowel disease. Inflamm Bowel Dis. 2002;8:325-329.
10. White JM, OConnor S, Winter HS, et al. Inflammatory bowel disease in African American children compared with other racial/ethnic groups in a multicenter registry. Clin Gastroenterol Hepatol. 2008;6:1361-1369.
11. Dallman PR, Siimes MA. Percentile curves for hemoglobin and red cell volume in infancy and childhood. J Pediatr. 1979;94:26-31.
12. Mack DR, Langton C, Markowitz J, et al. Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics. 2007;119: 1113-1119.
13. ThayuM, Leonard MB, Baldassano RN, et al. Prevalence of anemia in incident pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2005;41:547-548.
14. Quail MA, Russell RK, Van Limbergen JE, et al. Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:756-759.
15. Gerasimidis K, Nikolaou CK, Edwards CA, et al. Serial fecal calprotectin changes in children with Crohns disease on treatment with exclusive enteral nutrition: Associations with disease activity, treatment response, and prediction of a clinical relapse. J Clin Gastroenterol. 2011;45:234-239.
16. Otley AR, Russell RK, Day AS. Nutritional therapy for the treatment of pediatric Crohns disease. Expert Rev Clin Immunol. 2010;6:667-676.
17. Kugathasan S, Nebel J, Skelton JA, et al. Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr. 2007;151:523-527.
18. Cameron FL, Gerasimidis K, Papangelou A, et al. Clinical progress in the two years following a course of exclusive enteral nutrition in 109 paediatric patients with Crohns disease. Aliment Pharmacol Ther. 2013;37: 622-629.
19. Buchanan E, Gaunt WW, Cardigan T, et al. The use of exclusive enteral nutrition for induction of remission in children with Crohns disease demonstrates that disease phenotype does not influence clinical remission. Aliment Pharmacol Ther. 2009;30:501-507.
20. Gerasimidis K, Talwar D, Duncan A, et al. Impact of exclusive enteral nutrition on body composition and circulating micronutrients in plasma and erythrocytes of children with active Crohns disease. Inflamm Bowel Dis. 2012;18:1672-1681.
21. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis-the Porto criteria. J Pediatr Gastroenterol Nutr. 2005;41:1-7.
22. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(suppl A):5-36.
23. Cole TJ, Freeman JV, Preece MA. Body mass index reference curves for the UK, 1990. Arch Dis Child. 1995;73:25-29.
24. Armitage E, Drummond HE, Wilson DC, et al. Increasing incidence of both juvenile-onset Crohns disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol. 2001;13:1439-1447.
25. Heyman MB, Kirschner BS, Gold BD, et al. Children with early-onset inflammatory bowel disease (IBD): Analysis of a pediatric IBD consortium registry. J Pediatr. 2005;146:35-40.
26. Nissenson AR. Epoetin and cognitive function. Am J Kidney Dis. 1992; 20:21-24.
27. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090-2093.
28. Gryboski JD. Crohns disease in children 10 years old and younger: comparison with ulcerative colitis. J Pediatr Gastroenterol Nutr. 1994; 18:174-182.
29. Lomer MC, Cook WB, Jan-Mohamed HJ, et al. Iron requirements based upon iron absorption tests are poorly predicted by haematological indices in patients with inactive inflammatory bowel disease. Br J Nutr. 2012;107: 1806-1811.
30. Lomer MC, Kodjabashia K, Hutchinson C, et al. Intake of dietary iron is low in patients with Crohns disease: A case-control study. Br J Nutr. 2004;91:141-148.
31. Oustamanolakis P, Koutroubakis IE, Kouroumalis EA. Diagnosing anemia in inflammatory bowel disease: beyond the established markers. J Crohns Colitis. 2011;5:381-391.
32. Revel-Vilk S, Tamary H, Broide E, et al. Serum transferrin receptor in children and adolescents with inflammatory bowel disease. Eur J Pediatr. 2000;159:585-589.
33. Levine A, Milo T, Buller H, et al. Consensus and controversy in the management of pediatric Crohn disease: An international survey. J Pediatr Gastroenterol Nutr. 2003;36:464-469.
34. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohns disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439-447.
35. Thomas DW, Sinatra FR. Screening laboratory tests for Crohns disease. West Med J. 1989;150:163-164.